A recent study by researchers, including those from Baylor and the Histiocytosis Program at Texas Children’s Cancer Center, has uncovered important advances in the understanding of a rare blood disorder called Langerhans cell histiocytosis.
Two Baylor College of Medicine researchers have received grants from the nonprofit organization Alex’s Lemonade Stand Foundation to advance their immunotherapy-based treatment approaches for childhood cancer.
Baylor researchers find new genetic test helped provide a diagnosis to 25 percent of the first 250 such patients referred to the Baylor Whole Genome Laboratory, demonstrating the value of such technology to individual patients.
Dr. Meenakshi Hegde, instructor of pediatrics – hematology/oncology at Baylor College of Medicine, was awarded the 28th Schweisguth Prize from the International Society of Pediatric Oncology for the best scientific paper written by a trainee.
Baylor College of Medicine researchers have received a total of $600,000 in grants from Alex's Lemonade Stand Foundation to support their research to find innovative new treatments for childhood cancer.
A phase 1 clinical trial at Baylor College of Medicine, which has received support from a pediatric cancer nonprofit organization, will use an immunotherapy approach to treating kids with neuroblastoma.